Oregon Therapeutics Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Oregon Therapeutics General Information

Description

Developer of new anti-cancer drugs intended to serve the people of France. The company's drugs are created from chemical molecules targeting groups of enzymes involved in cell metabolism, enabling cancer patients to get anti-cancer drugs for their treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oregon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Feb-2020 Completed Out of Business
1. Accelerator/Incubator 20-Mar-2015 Completed Generating Revenue
To view Oregon Therapeutics’s complete valuation and funding history, request access »

Oregon Therapeutics FAQs

  • Where is Oregon Therapeutics headquartered?

    Oregon Therapeutics is headquartered in Paris, France.

  • What industry is Oregon Therapeutics in?

    Oregon Therapeutics’s primary industry is Drug Discovery.

  • Is Oregon Therapeutics a private or public company?

    Oregon Therapeutics is a Private company.

  • What is Oregon Therapeutics’s current revenue?

    The current revenue for Oregon Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »